Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behçet’s disease-Reference-Cited by-同舟云学术

Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behçet’s disease

Published:2019-04 Issue:2 Volume:46 Page:108-112
ISSN:1110-161X
Container-title:Egyptian Rheumatology and Rehabilitation
language:en
Short-container-title:Egypt Rheumatol Rehabil

Author:

Fouad Nermeen A.,Ahmed Tarek I.,Shaker Olfat G.,Abdelaleem Omayma O.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.4103/err.err_66_18.pdf

Reference23 articles.

1. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population based prevalence study of Behcet’s disease differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58:3951–3959.

2. Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, Hajialiloo M, Ghojazadeh M, Taei R, Kolahi S. The status of serum vitamin D in patients with active Behcet’s disease compared with controls. Int J Rheum Dis 2014; 17:430–434.

3. Gheita TA, Raafat H, Khalil H, Hussein Serum H. Level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity. Mod Rheumatol 2013; 23:542–546.

4. Gheita TA, Gamal SM, Shaker I, El Fishawy HS, El Sisi R, Shaker OG, et al. Clinical significance of serum interleukin-23 and A/G gene (rs17375018) polymorphism in Behçets disease: relation to neuro-Behçet, uveitis and disease activity. Joint Bone Spine 2015; 82:213–215.

5. Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Serum oxidant/antioxidant status in patients with Behçet’s disease. Ann Clin Lab Sci 2002; 32:377–382.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of calprotectin and ischemia-modified albumin serum levels as biomarkers to measure disease activity in Behçet’s disease;Egyptian Rheumatology and Rehabilitation;2023-10-10

2. Value of ischemia-modified albumin in ankylosing spondylitis;Journal of Surgery and Medicine;2023-09-19

3. Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases;Medicina;2022-05-17

4. Ischemia-modified albumin levels are elevated, and thiol/disulfite homeostasis is impaired in Behçet’s disease;Ulusal Romatoloji Dergisi;2022-04-27

5. Behçet Hastalarında Metilglioksal, İskemi Modifiye Albumin Düzeyleri ve Prolidaz Aktivitesinin Araştırılması;Harran Üniversitesi Tıp Fakültesi Dergisi;2020-08-20